ALACHUA, Fla., Jul 22, 2010 (BUSINESS WIRE) — RTI Biologics Inc. (RTI) (RTIX 2.86, +0.06, +2.14%) , a leading processor of orthopedic and other biologic implants, announced today that Dean H. Bergy, 50, of Stryker Corporation has joined the company’s board of directors. He will be up for re-election in 2012. More »
ALACHUA, Fla.–(BUSINESS WIRE)–RTI Biologics Inc. (RTI) (Nasdaq: RTIX – News), a leading processor of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year ending Dec. 31, 2009. More »
| Nuvasive, Inc. | 32.77 | ||
| Zimmer Holdings, | 52.99 | ||
| Alphatec Holdings | 4.23 | ||
| Smith & Nephew Sn | 43.62 | ||
| Trans1 Inc. | 2.49 | ||
| Medtronic Inc. Co | 36.97 | ||
| Synthes | 119.80 | ||
| Rti Biologics, In | 2.89 | ||
| Johnson & Johnson | 58.09 | ||
| Orthofix Internat | 30.28 | ||
| Covidien Plc. Ord | 37.32 | ||
| Orthovita, Inc. | 1.85 |
Archive for Publications »
